Neurona Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $120M

  • Investors
  • 24

Neurona Therapeutics General Information

Description

Operator of a clinical-stage biotherapeutics company intended to develop regenerative neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. The company specializes in creating neuronal, glial, and gene-edited cell therapy candidates to generate specific types of nerve cells for targeted delivery into the injured nervous system, enabling physicians to integrate and repair dysregulated neural circuits and accelerate their treatments for patients with significant unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 170 Harbor Way
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Neurona Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurona Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series E) 06-Feb-2024 $120M 00000 00000 Completed Clinical Trials - Phase 1
10. Later Stage VC (Series D) 22-Dec-2022 0000 00000 00000 Completed Clinical Trials - Phase 1
9. Grant 26-May-2022 000 000.00 Completed Clinical Trials - Phase 1
8. Debt - PPP 30-Apr-2020 00000 000.00 Completed Pre-Clinical Trials
7. Later Stage VC (Series C) 25-Nov-2019 0000 000.00 Completed Pre-Clinical Trials
6. Grant 31-Oct-2019 00.000 000.00 Completed Pre-Clinical Trials
5. Grant 01-Oct-2018 00.000 000.00 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) 26-Feb-2018 0000 000.00 Completed Pre-Clinical Trials
3. Later Stage VC (Series A) 28-Dec-2016 $28.7M $28.8M 000.00 Completed Pre-Clinical Trials
2. Angel (individual) 14-Aug-2008 $95K $95K Completed Startup
To view Neurona Therapeutics’s complete valuation and funding history, request access »

Neurona Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 000
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 000
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 16,703,606 $0.000100 $0.1 $1.2 $1.2 1x $1.2 7.52%
Series A 31,867,492 $0.000100 $0.07 $0.9 $0.9 1x $0.9 14.34%
To view Neurona Therapeutics’s complete cap table history, request access »

Neurona Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotherapeutics company intended to develop regenerative neural cell therapies with single-
Biotechnology
South San Francisco, CA
48 As of 2024
00000
00000 0000-00-00
00000000000 00000

000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000 000000000
San Carlos, CA
00 As of 0000
000.00
00000000000 000.00

000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000 000000000
Germantown, MD
000 As of 0000
000.00
000000000-00 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurona Therapeutics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CuraSen Venture Capital-Backed San Carlos, CA 00 000.00 00000000000 000.00
Orgenesis Corporation Germantown, MD 000 000.00 000000000-00 000.00
Panbela Therapeutics Corporation Waconia, MN 0 0000 00000000 0000
ViaCyte Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
BlueRock Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000&0 00000
You’re viewing 5 of 13 competitors. Get the full list »

Neurona Therapeutics Patents

Neurona Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7138959-B2 Methods of generating neural progenitor cell populations Active 08-Oct-2015 000000000 0
JP-2020202865-A Neural precursor cell populations and uses thereof Active 08-Oct-2015 000000000 0
JP-2018529389-A Neural progenitor cell populations and their use Pending 08-Oct-2015 000000000
JP-2022169768-A In vitro compositions comprising neural progenitor cell populations and uses thereof Pending 08-Oct-2015 000000000
US-20180369287-A1 Neural precursor cell populations and uses thereof Pending 08-Oct-2015 A61K35/30
To view Neurona Therapeutics’s complete patent history, request access »

Neurona Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Cory Nicholas Ph.D Co-Founder, Chief Executive Officer & Board Member
James Stutz Chief Financial Officer & Chief Business Officer
Gautam Banik Ph.D Chief Technology Officer
Catherine Priest Ph.D Chief Development Officer
Arturo Álvarez-Buylla Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

Neurona Therapeutics Board Members (10)

Name Representing Role Since
Arnold Kriegstein Ph.D Neurona Therapeutics Co-Founder, Board Member & Scientific Advisor 000 0000
Bradley Margus Self Board Member 000 0000
Cory Nicholas Ph.D Neurona Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
David Goeddel Ph.D The Column Group Board Member 000 0000
Erica Whittaker Ph.D UCB Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Neurona Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurona Therapeutics Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cormorant Asset Management Hedge Fund Minority 000 0000 000000 0
LYFE Capital Venture Capital Minority 000 0000 000000 0
Schroders Capital Fund of Funds Minority 000 0000 000000 0
UC Investments Asset Manager Minority 000 0000 000000 0
Viking Global Investors Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »

Neurona Therapeutics FAQs

  • When was Neurona Therapeutics founded?

    Neurona Therapeutics was founded in 2008.

  • Who is the founder of Neurona Therapeutics?

    Cory Nicholas Ph.D, Arturo Álvarez-Buylla Ph.D, John Rubenstein Ph.D, and Arnold Kriegstein Ph.D are the founders of Neurona Therapeutics.

  • Who is the CEO of Neurona Therapeutics?

    Cory Nicholas Ph.D is the CEO of Neurona Therapeutics.

  • Where is Neurona Therapeutics headquartered?

    Neurona Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Neurona Therapeutics?

    Neurona Therapeutics has 48 total employees.

  • What industry is Neurona Therapeutics in?

    Neurona Therapeutics’s primary industry is Biotechnology.

  • Is Neurona Therapeutics a private or public company?

    Neurona Therapeutics is a Private company.

  • What is the current valuation of Neurona Therapeutics?

    The current valuation of Neurona Therapeutics is 00000.

  • What is Neurona Therapeutics’s current revenue?

    The current revenue for Neurona Therapeutics is 000000.

  • How much funding has Neurona Therapeutics raised over time?

    Neurona Therapeutics has raised $246M.

  • Who are Neurona Therapeutics’s investors?

    Cormorant Asset Management, LYFE Capital, Schroders Capital, UC Investments, and Viking Global Investors are 5 of 24 investors who have invested in Neurona Therapeutics.

  • Who are Neurona Therapeutics’s competitors?

    CuraSen, Orgenesis, Panbela Therapeutics, ViaCyte, and BlueRock Therapeutics are some of the 13 competitors of Neurona Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »